TARLATAMAB for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where TARLATAMAB was used for Product used for unknown indication.
Most Reported Side Effects for TARLATAMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 59 | 40.7% | 11 | 32 |
| Death | 31 | 21.4% | 31 | 5 |
| Immune effector cell-associated neurotoxicity syndrome | 30 | 20.7% | 6 | 15 |
| Off label use | 14 | 9.7% | 2 | 6 |
| Disease progression | 11 | 7.6% | 6 | 3 |
| Small cell lung cancer | 10 | 6.9% | 3 | 2 |
| Metastases to central nervous system | 7 | 4.8% | 2 | 2 |
| Therapy partial responder | 7 | 4.8% | 4 | 3 |
| Pyrexia | 6 | 4.1% | 2 | 3 |
| Dysgeusia | 5 | 3.5% | 1 | 2 |
| Hypotension | 5 | 3.5% | 1 | 4 |
Other Indications for TARLATAMAB
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)